Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × Methylprednisolone × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 6 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Biphenotypic, Acute 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphohistiocytosis, Hemophagocytic 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hepatectomy 1 Hematologic Neoplasms 1 Down Syndrome 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Acute Gout 1

Interventions

Vincristine 2 Prednisone 2 Gemcitabine 2 Cyclophosphamide 2 Biopsy 2 tazemetostat 1 sodium-iodide symporter 1 sintilimab 1 ruxolitinib 1 romidepsin 1 ivarmacitinib 1 etoposide phosphate 1 duvelisib 1 cemiplimab 1 belinostat 1 X-Rays 1 Watchful Waiting 1 Specimen Handling 1 Prednisolone 1 Photons 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Immunoglobulin G 1 Etoposide 1 Doxorubicin 1 Disulfides 1 Dexamethasone 1 Cytarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡